Financhill
Sell
23

ASTC Quote, Financials, Valuation and Earnings

Last price:
$2.80
Seasonality move :
-0.96%
Day range:
$2.70 - $2.90
52-week range:
$2.47 - $8.01
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.95x
P/B ratio:
0.32x
Volume:
16.4K
Avg. volume:
11.5K
1-year change:
-58.4%
Market cap:
$4.9M
Revenue:
$1M
EPS (TTM):
-$8.26
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Revenue $334K $869K $750K $1.7M $1M
Revenue Growth (YoY) -31.56% 160.18% -13.69% 121.87% -36.96%
 
Cost of Revenues $298K $677K $567K $1.1M $1.7M
Gross Profit $36K $192K $183K $608K -$681K
Gross Profit Margin 10.78% 22.09% 24.4% 36.54% -64.92%
 
R&D Expenses $2.7M $2.8M $5.6M $6.8M $8.1M
Selling, General & Admin $4.7M $6M $5.8M $7.2M $7.1M
Other Inc / (Exp) -$206K $265K $1.4M $1.6M --
Operating Expenses $7.4M $8.8M $11.2M $13.9M $14.1M
Operating Income -$7.4M -$8.6M -$11.1M -$13.3M -$14.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$7.6M -$8.3M -$9.6M -$11.7M -$13.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $2K $2K
Net Income to Company -$7.6M -$8.3M -$9.6M -$11.7M -$13.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$7.6M -$8.3M -$9.6M -$11.7M -$13.9M
 
Basic EPS (Cont. Ops) -$10.50 -$5.24 -$5.95 -$7.12 -$8.32
Diluted EPS (Cont. Ops) -$10.50 -$5.24 -$5.95 -$7.12 -$8.32
Weighted Average Basic Share $732.8K $1.6M $1.6M $1.6M $1.7M
Weighted Average Diluted Share $732.8K $1.6M $1.6M $1.6M $1.7M
 
EBITDA -$7.2M -$8.4M -$10.6M -$12.4M -$13.6M
EBIT -$7.4M -$8.6M -$11.1M -$13.3M -$14.7M
 
Revenue (Reported) $334K $869K $750K $1.7M $1M
Operating Income (Reported) -$7.4M -$8.6M -$11.1M -$13.3M -$14.7M
Operating Income (Adjusted) -$7.4M -$8.6M -$11.1M -$13.3M -$14.7M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $561K $263K $1.1M $261K $148K
Revenue Growth (YoY) 331.54% -53.12% 323.95% -76.59% -43.3%
 
Cost of Revenues $441K $155K $619K $380K $433K
Gross Profit $120K $108K $496K -$119K -$285K
Gross Profit Margin 21.39% 41.07% 44.48% -45.59% -192.57%
 
R&D Expenses $652K $1.4M $1.6M $2.4M $1.8M
Selling, General & Admin $1.7M $1.6M $2M $2M $2.1M
Other Inc / (Exp) $80K $396K $427K $312K --
Operating Expenses $2.4M $2.9M $3.6M $4.2M $3.6M
Operating Income -$2.3M -$2.8M -$3.1M -$4.3M -$3.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$2.2M -$2.4M -$2.6M -$4M -$3.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$2.2M -$2.4M -$2.6M -$4M -$3.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$2.2M -$2.4M -$2.6M -$4M -$3.9M
 
Basic EPS (Cont. Ops) -$1.38 -$1.50 -$1.62 -$2.45 -$2.34
Diluted EPS (Cont. Ops) -$1.38 -$1.50 -$1.62 -$2.45 -$2.34
Weighted Average Basic Share $1.6M $1.6M $1.6M $1.6M $1.7M
Weighted Average Diluted Share $1.6M $1.6M $1.6M $1.6M $1.7M
 
EBITDA -$2.2M -$2.7M -$2.9M -$4M -$3.6M
EBIT -$2.3M -$2.8M -$3.1M -$4.3M -$3.9M
 
Revenue (Reported) $561K $263K $1.1M $261K $148K
Operating Income (Reported) -$2.3M -$2.8M -$3.1M -$4.3M -$3.9M
Operating Income (Adjusted) -$2.3M -$2.8M -$3.1M -$4.3M -$3.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $812K $422K $2M $419K $1.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $673K $441.5K $1.3M $1.3M $1.9M
Gross Profit $139K -$19.5K $726K -$843K -$702K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.6M $4M $6.4M $7.7M $7.5M
Selling, General & Admin $6.2M $6.1M $6.2M $7.3M $7.2M
Other Inc / (Exp) $564K $792K $1.6M $1.4M --
Operating Expenses $8.8M $9.8M $12.6M $14M $13.5M
Operating Income -$8.6M -$9.9M -$11.9M -$14.8M -$14.2M
 
Net Interest Expenses $113K -- -- -- --
EBT. Incl. Unusual Items -$8.1M -$9.1M -$10.2M -$13.4M -$14M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $2K $2K
Net Income to Company -$4.3M -$9.1M -$10.2M -$13.4M -$14M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$8.1M -$9.1M -$10.2M -$13.4M -$14M
 
Basic EPS (Cont. Ops) -$7.52 -$5.59 -$6.25 -$8.13 -$8.26
Diluted EPS (Cont. Ops) -$7.52 -$5.59 -$6.25 -$8.13 -$8.26
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$8.5M -$9.5M -$11.2M -$13.8M -$13M
EBIT -$8.6M -$9.9M -$11.9M -$14.8M -$14.2M
 
Revenue (Reported) $812K $422K $2M $419K $1.2M
Operating Income (Reported) -$8.6M -$9.9M -$11.9M -$14.8M -$14.2M
Operating Income (Adjusted) -$8.6M -$9.9M -$11.9M -$14.8M -$14.2M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $748K $301K $1.5M $295K $445K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $616K $276K $897K $673K $844K
Gross Profit $132K $25K $643K -$378K -$399K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.3M $2.5M $3.5M $4.4M $3.8M
Selling, General & Admin $3.2M $3.2M $3.7M $3.7M $3.9M
Other Inc / (Exp) $104K $631K $850K $662K --
Operating Expenses $4.4M $5.6M $7M $7.6M $7M
Operating Income -$4.3M -$5.6M -$6.4M -$7.9M -$7.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$4.2M -$4.9M -$5.6M -$7.3M -$7.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$4.2M -$4.9M -$5.6M -$7.3M -$7.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.2M -$4.9M -$5.6M -$7.3M -$7.4M
 
Basic EPS (Cont. Ops) -$2.66 -$3.07 -$3.40 -$4.46 -$4.41
Diluted EPS (Cont. Ops) -$2.58 -$3.07 -$3.40 -$4.46 -$4.41
Weighted Average Basic Share $3.2M $3.2M $3.3M $3.3M $3.3M
Weighted Average Diluted Share $3.2M $3.2M $3.3M $3.3M $3.3M
 
EBITDA -$4.2M -$5.4M -$6M -$7.4M -$6.8M
EBIT -$4.3M -$5.6M -$6.4M -$7.9M -$7.4M
 
Revenue (Reported) $748K $301K $1.5M $295K $445K
Operating Income (Reported) -$4.3M -$5.6M -$6.4M -$7.9M -$7.4M
Operating Income (Adjusted) -$4.3M -$5.6M -$6.4M -$7.9M -$7.4M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Cash and Equivalents $35.9M $52.6M $42.1M $31.9M $18.2M
Short Term Investments $27.4M $26.2M $27.9M $21.5M --
Accounts Receivable, Net $5K $56K $225K $77K $485K
Inventory $1.5M $1.5M $2M $2.5M $2.9M
Prepaid Expenses $318K -- -- -- --
Other Current Assets -- $748K $365K $261K --
Total Current Assets $65.1M $55M $44.7M $34.7M $22M
 
Property Plant And Equipment $512K $1.3M $2.9M $2.9M $4.6M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $11K $11K $30K $30K --
Total Assets $65.6M $56.2M $47.7M $37.6M $27M
 
Accounts Payable $396K $169K $546K $373K $1.1M
Accrued Expenses $1.2M $1.8M $1.8M $1.9M --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $81K $234K $316K $227K --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.2M $2.7M $2.7M $2.5M $2.5M
 
Long-Term Debt -- $303K $291K $73K $2.3M
Capital Leases -- -- -- -- --
Total Liabilities $4.4M $3M $3M $2.8M $4.9M
 
Common Stock $190.6M $190.6M $190.6M $190.6M $190.6M
Other Common Equity Adj -$23K -$1.2M -$1.5M -$1.2M --
Common Equity $61.2M $53.2M $44.7M $34.8M $22.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $61.2M $53.2M $44.7M $34.8M $22.1M
 
Total Liabilities and Equity $65.6M $56.2M $47.7M $37.6M $27M
Cash and Short Terms $63.3M $52.6M $42.1M $31.9M $18.2M
Total Debt $2.5M $442K $459K $162K $2.3M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $57.3M $46.8M $37.3M $24.7M $10.1M
Short Term Investments $27.1M $31M $26.2M $21.5M --
Accounts Receivable, Net $92K $112K $294K $340K $133K
Inventory $1.4M $1.5M $2.1M $2.6M $3.7M
Prepaid Expenses $516K -- -- -- --
Other Current Assets -- $979K $426K $478K --
Total Current Assets $59.3M $49.4M $40.1M $28.2M $14.3M
 
Property Plant And Equipment $1.1M $1.9M $2.7M $2.8M $5M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $11K $11K $30K $30K --
Total Assets $60.4M $51.3M $42.8M $31M $19.7M
 
Accounts Payable $90K $301K $567K $1M $649K
Accrued Expenses $1.6M $1.7M $1.4M $1.5M --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $227K $291K $309K $81K --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.4M $2.3M $2.3M $2.6M $1.9M
 
Long-Term Debt $421K $356K $152K $61K $2.2M
Capital Leases -- -- -- -- --
Total Liabilities $2.8M $2.6M $2.6M $2.9M $4.2M
 
Common Stock $190.6M $190.6M $190.6M $190.6M $190.6M
Other Common Equity Adj -$268K -$1.6M -$1.2M -$1.1M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $57.6M $48.7M $40.3M $28.1M $15.5M
 
Total Liabilities and Equity $60.4M $51.3M $42.8M $31M $19.7M
Cash and Short Terms $57.3M $46.8M $37.3M $24.7M $10.1M
Total Debt $556K $499K $301K $86K $2.2M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders -$7.6M -$8.3M -$9.6M -$11.7M -$13.9M
Depreciation & Amoritzation $203K $236K $489K $874K $1.2M
Stock-Based Compensation $626K $1.5M $1.5M $1.5M $830K
Change in Accounts Receivable $525K -$51K -$168K $148K -$408K
Change in Inventories -$824K -$18K -$477K -$479K -$455K
Cash From Operations -$7.4M -$6.8M -$7.6M -$9.7M -$13M
 
Capital Expenditures $211K $596K $1.8M $579K $883K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$27.6M -$596K -$3.8M $6.1M $5.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$12K -$2.1M -$657K -$181K --
Repurchase of Common Stock -- -- $119K -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $67.6M -$2.1M -$776K -$181K -$185K
 
Beginning Cash (CF) $3.3M $26.5M $14.2M $10.4M $3.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $32.6M -$9.5M -$12.2M -$3.8M -$7.3M
Ending Cash (CF) $35.9M $17M $2M $6.7M -$4.2M
 
Levered Free Cash Flow -$7.6M -$7.4M -$9.5M -$10.3M -$13.8M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$2.2M -$2.4M -$2.6M -$4M -$3.9M
Depreciation & Amoritzation $55K $110K $188K $274K $293K
Stock-Based Compensation $439K $404K $473K $261K $189K
Change in Accounts Receivable $114K -$78K $96K -$253K $220K
Change in Inventories $281K -$31K $126K $49K -$733K
Cash From Operations -$1.3M -$1.8M -$1.8M -$3M -$3.5M
 
Capital Expenditures $167K $286K $153K $319K $411K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$167K -$531K -$149K -$279K $4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$15K -$39K -$45K -$34K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$18K -$39K -$45K -$34K -$18K
 
Beginning Cash (CF) $30.2M $15.9M $11.1M $3.2M $3.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.5M -$2.4M -$2M -$3.4M $449K
Ending Cash (CF) $28.7M $13.5M $9.1M -$196K $3.5M
 
Levered Free Cash Flow -$1.5M -$2.1M -$2M -$3.4M -$4M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$4.3M -$9.1M -$10.2M -$13.4M -$14M
Depreciation & Amoritzation $156K $341K $663K $1M $1.2M
Stock-Based Compensation $1.3M $1.5M $1.5M $1.1M $846K
Change in Accounts Receivable $3K -$22K -$179K -$50K $211K
Change in Inventories -$826K -$83K -$567K -$585K -$1.2M
Cash From Operations -$8.4M -$7.6M -$8.2M -$11.6M -$13.7M
 
Capital Expenditures $459K $964K $1.4M $914K $1.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$27.8M -$6.1M $3.7M $3.8M $13.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2M -$654K -$170K -$170K --
Repurchase of Common Stock -- -- $119K -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $43.7M -$654K -$289K -$170K -$160K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $7.5M -$14.3M -$4.8M -$7.9M -$66K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$8.9M -$8.5M -$9.6M -$12.5M -$14.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$4.2M -$4.9M -$5.6M -$7.3M -$7.4M
Depreciation & Amoritzation $94K $199K $373K $542K $595K
Stock-Based Compensation $798K $791K $837K $477K $493K
Change in Accounts Receivable -$87K -$58K -$69K -$267K $352K
Change in Inventories $86K $21K -$69K -$175K -$886K
Cash From Operations -$3.5M -$4.3M -$4.9M -$6.7M -$7.5M
 
Capital Expenditures $264K $632K $177K $512K $859K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$264K -$5.7M $1.8M -$472K $7.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2M -$577K -$90K -$79K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$2M -$577K -$90K -$79K -$54K
 
Beginning Cash (CF) $61.8M $34.2M $24.2M $9.7M $5.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$5.8M -$10.6M -$3.1M -$7.3M -$5K
Ending Cash (CF) $56.1M $23.6M $21.1M $2.4M $5.7M
 
Levered Free Cash Flow -$3.7M -$4.9M -$5M -$7.2M -$8.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 23

RingCentral, Inc. [RNG] is down 11.11% over the past day.

Sell
9
FROG alert for Feb 23

JFrog Ltd. [FROG] is down 5.38% over the past day.

Buy
72
SNSE alert for Feb 23

Sensei Biotherapeutics, Inc. [SNSE] is down 4.09% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock